Artículos del autor

solaci

Highlights ACC 2016

Morphine Increases Platelet Reactivity in Infarctions

The use of morphine in patients undergoing ST elevation acute coronary syndromes is associated to higher platelet...
solaci -
Highlights ACC 2016

EARLY-BAMI: Metropol Showed No Reduction in Infarct Size.

EARLY-BAMI outcomes show the endovenous administration of metropol before primary PCI does not reduce infarct size. This double...
solaci -
Highlights ACC 2016

New Meta-Analysis Shows Similar Mortality between Bivalirudin and Heparin

This meta-analyzis of contemporary studies comparing the safety and efficacy of bivalirudin vs. heparin showed no differences...
solaci -
Highlights ACC 2016

HOPE 3: Reducing LDL Improves Prognosis in Intermediate Risk Patients

In a large cohort of intermediate risk patients with no known CAD, treatment with low doses of...
solaci -
Highlights ACC 2016

ixCELL-DCM: Stem Cell Therapy Improves Outcomes in Patients with Heart Failure

Enhanced autologous bone marrow stem cell therapy improves clinical cardiac events in patients with heart failure and...
solaci -
ACC 2016

ACC 2016

65th Annual Scientific Session & Expo. April 2 - 4, 2016. Chicago. Find here the highlights from...
solaci -
Acute coronary syndromes

Optimal Duration of Dual Antiplatelet Therapy: New ACC-AHA Guidelines

Original Title: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary...
solaci -
Chronic Ischemic cardiopathy

Heart Disease with Typical Symptoms and Negative Stress Test

Original Title: Effect of the presence and type of angina on cardiovascular events in patients without known...
solaci -